tao xu
University of Florida
Gainesville, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
Type at least 3 characters
722 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
xiaowei xu
University of Arkansas at Little Rock
Little Rock, United States
Review Editor
In silico Methods and Artificial Intelligence for Drug Discovery
yong xu
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (CAS)
Guangzhou, China
Review Editor
Anti-Cancer Drugs
ziyi xu
Boston University
Boston, United States
Review Editor
Anti-Infective Agents
fengtian xue
University of Maryland
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
jingyi xue
King's College London
London, United Kingdom
Review Editor
Technologies and Strategies to Enable Drug Discovery
yan-yan yan
Shanxi Datong University
Datong, China
Review Editor
Anti-Cancer Drugs
chao yang
Exo Therapeutics
Cambridge, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
fengyuan yang
Chongqing University
Chongqing, China
Review Editor
Anti-Infective Agents
zhaogang yang
Jilin University
Changchun, China
Review Editor
Anti-inflammatory and Immunomodulating Agents
xiao jun yao
Macau University of Science and Technology
Taipa, China
Review Editor
Anti-Cancer Drugs
nageswari yarravarapu
University of Texas Southwestern Medical Center
Dallas, United States
Review Editor
Anti-Cancer Drugs
fei ye
Harvard Medical School
Boston, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
cui-yun yu
University of South China
Hengyang, China
Review Editor
Anti-Cancer Drugs
kai yu
Arcus Biosciences
Hayward, United States
Review Editor
Technologies and Strategies to Enable Drug Discovery
peng zhan
Shandong University
Jinan, China
Review Editor
Technologies and Strategies to Enable Drug Discovery